Earnings · US stocks

Inovio Pharmaceuticals, Inc. (INO) earnings

Inovio Pharmaceuticals, Inc. published its quarterly report on 2026-11-10. The stock moved -1.38% in the 3 trading days after the report.

Report
quarterly report
Published
2026-11-10
Result
Bad / loss
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day+2.07%—
3 days-1.38%—

Report history

Over the last 8 reports, EPS beat the consensus estimate in 6 of them. The stock rose in the 3 trading days after 3 of 8 reports (average +6.59%).

PublishedEPSEPS surprise3 days after30 days after30d vs index
2026-11-10-0.23-15.74%-1.38%——
2026-08-12-0.24+0.57%+49.35%+57.14%+57.83%
2026-05-13-0.31+4.71%-8.96%-17.91%-16.12%
2026-03-12-0.28+19.59%+0.00%-31.55%-38.74%
2025-11-10-0.87-82.77%-9.30%+0.00%-0.96%
2025-08-12-0.61+1.29%+24.83%+69.13%+66.26%
2025-05-13-0.51+31.08%+6.77%+17.19%+12.92%
2025-03-18-0.60+27.88%-8.57%-7.62%-6.46%

The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.

Stock valuations: INO · Stock news: INO

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.